3Yndgaard S,Andersen IW, Andersen C, et al. The effect of modified ultrafihration on the amount of circulating endotoxin in children undergoing cardiopulmonary bypass[ J]. J Cardiothorac vasc Anesth,2000,14(4) :399-401.
4Barst BJ.McGoon M,Torbicki A,et al.Diagnosis and differential assessment of pulmonary arterial hypertension.J Am Coll Cardi- ol, 2004,43 : 40-47.
5Oechslin EN, Harrison DA, Connelly MS,et al.Mode of death in adults with congenital heart disease.Am J Cardiol,2000,86 (10):1111-1116.
6Shah PS,Hellmann J,Adatia I.Clinical characteristics and fol- low up of down ayndrome infants without congenital heart dis- ease who presented with persistent pulmonary hypertention of newborn.J Perinat Med, 2004,32(2) : 168-170.
7Zhou Q,Lai Y,Wei H,et al.Unidirectional valve patch for re- pair of cardiac septal defects with pulmonary hypertention.Ann Thorac Surg, 1995,60(5 ) : 1245-1249.
8Tone DM,Frattarelli DA,Karthikeyan S,et al.Altered prostaglandin E1 dosage during extracorporeal membrane oxygenation in a newborn with ductal-dependent congenital heart disease.Pediatr Cardiol, 2006,27 (3) : 360-363.
